Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets

Journal of Virological Methods

Volumn 178, Issue 1-2, 2011, Pages 68-74

  Camargo, Milena ^a,b   Soto De Leon, Sara ^a,b   Sanchez, Ricardo ^a,c   Munoz, Marina ^a,b   Vega, Erika ^a,b   Beltran, Magda ^a,b   Perez Prados, Antonio ^d   Patarroyo, Manuel Elkin ^a,c   Patarroyo, Manuel Alfonso ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Colombia; GP5+ 6+; Human papillomavirus (HPV); Multiple infections; MY09 11

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BETA GLOBIN GENE; COLOMBIA; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; GENE; GENE DOSAGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERFORMANCE MEASUREMENT SYSTEM; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; COINFECTION; COLOMBIA; DNA PRIMERS; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 80955142754     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.08.014     Document Type: Article

References (34)

1. Baleriola C., Millar D., Melki J., Coulston N., Altman P., Rismanto N., Rawlinson W. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections. J. Clin. Virol. 2008, 42:22-26.
2. Bello B.D., Spinillo A., Alberizzi P., Cesari S., Gardella B., D'Ambrosio G., Roccio M., Silini E.M. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J. Med. Virol. 2009, 81:703-712.
3. Castle P.E., Porras C., Quint W.G., Rodriguez A.C., Schiffman M., Gravitt P.E., Gonzalez P., Katki H.A., Silva S., Freer E., Van Doorn L.J., Jimenez S., Herrero R., Hildesheim A. Comparison of two PCR-based human papillomavirus genotyping methods. J. Clin. Microbiol. 2008, 46:3437-3445.
4. Chaiwongkot A., Pientong C., Ekalaksananan T., Kongyingyoes B., Thinkhamrop J., Yuenyao P., Sriamporn S. Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells. Asian Pac. J. Cancer Prev. 2007, 8:279-282.
5. Coutlee F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., Voyer H., Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 2002, 40:902-907.
6. Dalstein V., Merlin S., Bali C., Saunier M., Dachez R., Ronsin C. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. J. Virol. Methods 2009, 156:77-83.
7. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 1995, 76(Pt. 4):1057-1062.
8. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
9. Depuydt C.E., Boulet G.A., Horvath C.A., Benoy I.H., Vereecken A.J., Bogers J.J. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J. Cell. Mol. Med. 2007, 11:881-891.
10. Ferrera A., Velema J.P., Figueroa M., Bulnes R., Toro L.A., Claros J.M., de Barahona O., Melchers W.J. Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras. Int. J. Epidemiol. 2000, 29:817-825.
11. Fuessel Haws A.L., He Q., Rady P.L., Zhang L., Grady J., Hughes T.K., Stisser K., Konig R., Tyring S.K. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J. Virol. Methods 2004, 122:87-93.
12. Gravitt P.E., Schiffman M., Solomon D., Wheeler C.M., Castle P.E. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1248-1254.
13. Herrero R., Hildesheim A., Rodriguez A.C., Wacholder S., Bratti C., Solomon D., Gonzalez P., Porras C., Jimenez S., Guillen D., Morales J., Alfaro M., Cyr J., Morrisey K., Estrada Y., Cortes B., Morera L.A., Freer E., Schussler J., Schiller J., Lowy D., Schiffman M. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine 2008, 26:4795-4808.
14. Iftner T., Villa L.L. Chapter 12: Human papillomavirus technologies. J. Natl. Cancer Inst. Monogr. 2003, 80-88.
15. Karlsen F., Kalantari M., Jenkins A., Pettersen E., Kristensen G., Holm R., Johansson B., Hagmar B. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 1996, 34:2095-2100.
16. Kreader C.A. Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein. Appl. Environ. Microbiol. 1996, 62:1102-1106.
17. Kulmala S.M., Syrjanen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J., Ivanchenko O., Zakharenko S., Nerovjna R., Kljukina L., Branovskaja M., Grunberga V., Juschenko A., Tosi P., Santopietro R., Syrjanen K. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J. Clin. Microbiol. 2004, 42:2470-2475.
18. Lee Y.M., Leu S.Y., Chiang H., Fung C.P., Liu W.T. Human papillomavirus type 18 in colorectal cancer. J. Microbiol. Immunol. Infect. 2001, 34:87-91.
19. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989, 7:209-214.
20. Mendez F., Munoz N., Posso H., Molano M., Moreno V., van den Brule A.J., Ronderos M., Meijer C., Munoz A. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 2005, 192:1158-1165.
21. Mo L.Z., Monnier-Benoit S., Kantelip B., Petitjean A., Riethmuller D., Pretet J.L., Mougin C. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results. J. Clin. Virol. 2008, 41:104-110.
22. Molano M., Posso H., Weiderpass E., van den Brule A.J., Ronderos M., Franceschi S., Meijer C.J., Arslan A., Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br. J. Cancer 2002, 87:324-333.
23. Nelson J.H., Hawkins G.A., Edlund K., Evander M., Kjellberg L., Wadell G., Dillner J., Gerasimova T., Coker A.L., Pirisi L., Petereit D., Lambert P.F. A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J. Clin. Microbiol. 2000, 38:688-695.
24. Parkin D.M., Almonte M., Bruni L., Clifford G., Curado M.P., Pineros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine 2008, 26(Suppl. 11):L1-L15.
25. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 1997, 35:1304-1310.
26. Remmerbach T.W., Brinckmann U.G., Hemprich A., Chekol M., Kuhndel K., Liebert U.G. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J. Clin. Virol. 2004, 30:302-308.
27. Safaeian M., Herrero R., Hildesheim A., Quint W., Freer E., Van Doorn L.J., Porras C., Silva S., Gonzalez P., Bratti M.C., Rodriguez A.C., Castle P. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 2007, 45:1447-1454.
28. Sierra-Torres C.H., Acosta-Aragón M.P., Orejuela-Aristizabal L. Papilomavirus and Factors Associated with High-Risk, Cervical Intra-Epithelial Neoplasia in Cauca, Colombia 2006, vol. 8. Revista de Salud Pública.
29. Sotlar K., Diemer D., Dethleffs A., Hack Y., Stubner A., Vollmer N., Menton S., Menton M., Dietz K., Wallwiener D., Kandolf R., Bultmann B. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J. Clin. Microbiol. 2004, 42:3176-3184.
30. Tabora N., Bakkers J.M., Quint W.G., Massuger L.F., Matute J.A., Melchers W.J., Ferrera A. Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes Control 2009, 20:1663-1670.
31. Tsiodras S., Georgoulakis J., Chranioti A., Voulgaris Z., Psyrri A., Tsivilika A., Panayiotides J., Karakitsos P. Hybrid capture vs PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women. BMC Cancer 2010, 10:53.
32. van Doorn L.J., Molijn A., Kleter B., Quint W., Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J. Clin. Microbiol. 2006, 44:3292-3298.
33. WHO HPV and cervical cancer in the 2007 report. Vaccine 2007, 25:C1-C230.
34. WHO/ICO, 2010. Information Centre on HPV and Cervical Cancer (HPV Information Centre) Human Papillomavirus and Related Cancers in Colombia. Summary Report January 29. Available at: (accessed 01.06.2010). http://www.who.int/hpvcentre.